αααααβααΎαALC β’ NYSE
add
Alcon AG
78.81$
αααααααααα(0.00%)0.00
78.81$
ααΆααα·αα 31 ααααΌ, 5:18:01 PM ααααβααα -5 · USD · NYSE · ααα
ααααΈαααααΆααα·αααα½ααα»αααααΌα
ααΆαβα αα»αααΌααααααααααΆαα
α»ααααααΈαα
α’αΆαααα·αααΆαααΈααααΆααααΆααααααΆααα
CH
αα·αααΈαα»α
79.32$
α
αααααααααααα
78.53$ - 79.46$
α
ααααααα½αααααΆαα
α»αααααα
71.55$ - 99.20$
ααΎαβαα»αβααΈααααΆα
31.62Β αααΈααΆα CHF
ααα ααα½αααΌαααααα
1.45Β ααΆα
α’αα»ααΆα P/E
-
αα·αααααβααΆαααΆα
-
ααΆααααααΌαα
αααα
SWX
αααα»αβααααααΆαβ
α α·ααααααααα»
αααΆαααΆαααααααΆααα
αααΌα
α
αααΌα
α
αααΌααα»ααα
| (USD) | αααααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌα | 2.61Β αααΈααΆα | 6.52% |
α
αααΆαααααα·ααααα·ααΆα | 1.12Β αααΈααΆα | 7.99% |
α
αααΌααα»ααα | 237.00Β ααΆα | -9.89% |
ααααΆααα
αααααα»ααα | 9.07 | -15.39% |
βα
αααΌααα»αααβαααα»ααα½αααΆαα αα»α | 0.79 | -2.47% |
α
αααΌααα»ααααα»αααΆαααααΆαα αααα ααΆαααααα αα·αααΆαααΆααααααα | 784.00Β ααΆα | 26.45% |
α’ααααΆαααααααααΆαααααα·αααααΆα | 16.25% | β |
αααααΈαααα»ααα
ααααααααα»α
ααΆαααα½ααα»αααααΌαααα»α
| (USD) | αααααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
ααΆα
αααααΆαα αα·αααΆααα·αα·αααααααααααααΈ | 1.50Β αααΈααΆα | -12.75% |
ααααααααα»α | 31.52Β αααΈααΆα | 3.83% |
ααΆαααα½ααα»αααααΌαααα»α | 9.44Β αααΈααΆα | 5.16% |
ααΌαβααααα»α | 22.09Β αααΈααΆα | β |
ααΆαα αα»αβαα·αβααΆααααΆαααα | 491.20Β ααΆα | β |
ααααααααααΉαααααα
| 1.76 | β |
ααα
ααααααΎαααααα | 2.67% | β |
ααα
ααααααΎααΎααα»α | 3.07% | β |
ααα αΌαβααΆα
αβααααΆααβ
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα
| (USD) | αααααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌααα»ααα | 237.00Β ααΆα | -9.89% |
ααΆα
αααααΆααααΈααααα·ααααα·ααΆα | 724.00Β ααΆα | -3.08% |
ααΆα
αααααΆααααΈααΆααα·αα·ααα | -312.00Β ααΆα | 35.40% |
ααΆα
αααααΆααααΈα α·ααααβαααααΆα | -310.00Β ααΆα | -282.72% |
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα | 90.00Β ααΆα | -53.61% |
ααα αΌαααΆα
αααααΆααααααα | 597.12Β ααΆα | 31.27% |
α’αααΈ
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
ααΆααααααΎαα‘αΎα
1945
ααΆαα·ααΆαααβαααααΆα
αααααβαααααΆα
αα»ααααα·α
25,000